Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Table_6_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx

Monica Franzese (8983097)
Luigi Coppola (2180326)
Romina Silva (3486734)
Stefano Angelo Santini (13886274)
Luigi Cinquanta (13886277)
Cosimo Ottomano (10189551)
Marco Salvatore (470253)
Mariarosaria Incoronato (197260)

September 2022

This study monitored the anti-spike-receptor-binding domain (RBD) and neutralizing antibodies induce...

Table_2_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx

Monica Franzese (8983097)
Luigi Coppola (2180326)
Romina Silva (3486734)
Stefano Angelo Santini (13886274)
Luigi Cinquanta (13886277)
Cosimo Ottomano (10189551)
Marco Salvatore (470253)
Mariarosaria Incoronato (197260)

September 2022

This study monitored the anti-spike-receptor-binding domain (RBD) and neutralizing antibodies induce...

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

August 2021

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavir...

Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy

Homan T.
Fortunato F.
Corso G.
Lopalco P. L.
Prato R.
Martinelli D.

January 2022

Introduction: Data have suggested that SARS-CoV-2 infection causes an antibody response at least as ...

Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply

Ferrara, Pietro
Antonazzo, Ippazio C.
Polosa, Riccardo

January 2022

Dear Editor, We read with interest the letter by Serraino and colleagues [1] as they report on our ...

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

October 2021

Background: To optimise the use of available SARS-CoV-2 vaccines, some advocate delaying second vacc...

Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine

Ferrari, Davide
Clementi, Nicola
Criscuolo, Elena
Ambrosi, Alessandro
Corea, Francesca
Di Resta, Chiara
Tomaiuolo, Rossella
Mancini, Nicasio
Locatelli, Massimo
Plebani, Mario
Banfi, Giuseppe

January 2021

Background: Studies reporting the long-term humoral response after receiving the BNT162b2 COVID-19 v...

Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine

Coppeta, Luca
Ferrari, Cristiana
Somma, Giuseppina
Mazza, Andrea
D'Ancona, Umberto
Marcuccilli, Fabbio
Grelli, Sandro
Aurilio, Marco Trabucco
Pietroiusti, Antonio
Magrini, Andrea
Rizza, Stefano

January 2022

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

Lozano-Ojalvo, Daniel
Camara, Carmen
Lopez-Granados, Eduardo
Nozal, Pilar
Del Pino-Molina, Lucía
Bravo-Gallego, Luz Yadira
Paz-Artal, Estela
Pion, Marjorie
Correa-Rocha, Rafael
Ortiz, Alberto
López Hoyos, Marcos
Iribarren, Marta Erro
Portoles, Jose
Rojo-Portoles, Maria Pilar
Ojeda, Gloria
Cervera, Isabel
Gonzalez-Perez, Maria
Bodega-Mayor, Irene
Montes-Casado, Maria
Portoles, Pilar

January 2021

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavir...

Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response

Jesús Ontañón
Joaquín Blas
Carlos de Cabo
Celia Santos
Elena Ruiz-Escribano
Antonio García
Luis Marín
Lourdes Sáez
José Luis Beato
Ramón Rada
Laura Navarro
Caridad Sainz de Baranda
Javier Solera
L Sáez
J Solera

November 2021

Background: SARS-CoV-2 vaccines are an invaluable resource against COVID-19. Current vaccine shortag...

Table_6_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx

Monica Franzese (8983097)
Luigi Coppola (2180326)
Romina Silva (3486734)
Stefano Angelo Santini (13886274)
Luigi Cinquanta (13886277)
Cosimo Ottomano (10189551)
Marco Salvatore (470253)
Mariarosaria Incoronato (197260)

September 2022

This study monitored the anti-spike-receptor-binding domain (RBD) and neutralizing antibodies induce...

Table_2_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx

Monica Franzese (8983097)
Luigi Coppola (2180326)
Romina Silva (3486734)
Stefano Angelo Santini (13886274)
Luigi Cinquanta (13886277)
Cosimo Ottomano (10189551)
Marco Salvatore (470253)
Mariarosaria Incoronato (197260)

September 2022

This study monitored the anti-spike-receptor-binding domain (RBD) and neutralizing antibodies induce...

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

August 2021

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavir...

Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine

Ferrari, Davide
Clementi, Nicola
Criscuolo, Elena
Ambrosi, Alessandro
Corea, Francesca
Di Resta, Chiara
Tomaiuolo, Rossella
Mancini, Nicasio
Locatelli, Massimo
Plebani, Mario
Banfi, Giuseppe

January 2021

Background: Studies reporting the long-term humoral response after receiving the BNT162b2 COVID-19 v...

Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine

Coppeta, Luca
Ferrari, Cristiana
Somma, Giuseppina
Mazza, Andrea
D'Ancona, Umberto
Marcuccilli, Fabbio
Grelli, Sandro
Aurilio, Marco Trabucco
Pietroiusti, Antonio
Magrini, Andrea
Rizza, Stefano

January 2022

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had a tremendous impac...

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

Lozano-Ojalvo, Daniel
Camara, Carmen
Lopez-Granados, Eduardo
Nozal, Pilar
Del Pino-Molina, Lucía
Bravo-Gallego, Luz Yadira
Paz-Artal, Estela
Pion, Marjorie
Correa-Rocha, Rafael
Ortiz, Alberto
López Hoyos, Marcos
Iribarren, Marta Erro
Portoles, Jose
Rojo-Portoles, Maria Pilar
Ojeda, Gloria
Cervera, Isabel
Gonzalez-Perez, Maria
Bodega-Mayor, Irene
Montes-Casado, Maria
Portoles, Pilar

January 2021

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavir...

Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response

Jesús Ontañón
Joaquín Blas
Carlos de Cabo
Celia Santos
Elena Ruiz-Escribano
Antonio García
Luis Marín
Lourdes Sáez
José Luis Beato
Ramón Rada
Laura Navarro
Caridad Sainz de Baranda
Javier Solera
L Sáez
J Solera

November 2021

Background: SARS-CoV-2 vaccines are an invaluable resource against COVID-19. Current vaccine shortag...

Table_6_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx

Monica Franzese (8983097)
Luigi Coppola (2180326)
Romina Silva (3486734)
Stefano Angelo Santini (13886274)
Luigi Cinquanta (13886277)
Cosimo Ottomano (10189551)
Marco Salvatore (470253)
Mariarosaria Incoronato (197260)

September 2022

This study monitored the anti-spike-receptor-binding domain (RBD) and neutralizing antibodies induce...

Table_2_SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤60 years: One year of surveillance.xlsx

Monica Franzese (8983097)
Luigi Coppola (2180326)
Romina Silva (3486734)
Stefano Angelo Santini (13886274)
Luigi Cinquanta (13886277)
Cosimo Ottomano (10189551)
Marco Salvatore (470253)
Mariarosaria Incoronato (197260)

September 2022

This study monitored the anti-spike-receptor-binding domain (RBD) and neutralizing antibodies induce...

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

August 2021

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavir...